The relationship between resting heart rate and incidence and progression of coronary artery calcification: The multi-ethnic study of atherosclerosis (MESA)

doi:10.1016/j.atherosclerosis.2011.06.033

Atherosclerosis

Volume 220, Issue 1, January 2012, Pages 194-200

https://doi.org/10.1016/j.atherosclerosis.2011.06.033 Get rights and content

Abstract

Objective

Elevated resting heart rate has been independently associated with cardiovascular and all-cause mortality. The pathophysiological mechanisms by which this increased risk occurs are unclear. We hypothesized that elevated resting heart rate will be associated with increased development of atherosclerosis, as assessed by the incidence and progression of coronary artery calcium (CAC).

Methods

The Multi-Ethnic Study of Atherosclerosis is a prospective cohort study of participants free of clinical cardiovascular disease at entry. Among persons without CAC at baseline, the association between increasing clinical categories of heart rate (<60, 61–70, 71–80, >80 bpm) and CAC incidence was assessed by relative risk regression after adjusting for covariates. Among those with detectable CAC at baseline, progression of CAC was assessed using multivariable robust linear regression.

Results

Our study population consisted of 6004 individuals (62 ± 10 years, 48% males). Among 3079 individuals with no detectable CAC at baseline, 20% (n = 620) developed CAC. After adjusting for CVD risk factors, participants with a baseline resting heart rate >80 bpm had an increased risk of incident CAC as compared to those with a resting heart rate <60 (relative risk = 1.65, 95% CI = 1.02, 2.66). Among persons with CAC present at baseline, participants with a baseline resting heart rate >80 bpm had greater CAC score progression than those with a resting heart rate <60 (β = 17.10; 95% CI = 4.29, 29.85).

Conclusion

Elevated resting heart rate, a well-described predictor of cardiovascular mortality with unclear mechanism, is associated with increased incidence and progression of coronary atherosclerosis among individuals free of CVD at baseline.

Introduction

Several studies have demonstrated that heart rate is a strong and independent predictor of sudden death, cardiovascular mortality, and all-cause mortality in both the general population and in those with preexisting cardiovascular disease [1], [2], [3], [4], [5]. The pathophysiological mechanisms by which this increased risk is thought to occur are unclear. Although some have postulated that increased sympathetic activity [6], [7], myocardial ischemia [8], arrhythmias [9] and atherosclerosis [9] may be implicated in the increased cardiovascular risk, limited studies examining this association are available.

The advent of non-invasive imaging techniques allows for the visualization of the atherosclerotic burden “in vivo”. Coronary artery calcium (CAC) scoring allows for the quantification of coronary artery calcification, strongly correlates with coronary plaque burden in pathologic specimens [10] and has demonstrated to improve risk prediction beyond that of traditional algorithms [11], [12].

To better understand the mechanisms by which resting heart rate is associated to increased cardiovascular risk, we tested the hypothesis that elevated resting heart rate is associated with development and progression of atherosclerosis—as assessed by the incidence and progression of CAC- in a population-based cohort of asymptomatic individuals. The Multi-Ethnic Study of Atherosclerosis (MESA) provides the ideal cohort to examine this association since both baseline and follow up CAC scores are available from a multi-ethnic population with systematically and rigorously assessed risk factors.

Section snippets

Study population

The Multi-Ethnic Study of Atherosclerosis is a prospective, community-based study designed to investigate the prevalence, correlates, and progression of subclinical cardiovascular disease in subjects without known cardiovascular disease at the baseline exam [13]. Briefly, women and men aged 45–84 years and free of clinical cardiovascular diseases were recruited from 6 communities in the United States (Baltimore, Maryland; Chicago, Illinois; Forsyth County, North Carolina, Los Angeles County,

Results

The final study population consisted of 6004 persons. Baseline characteristics of study participants are shown in Table 1. Increasing heart rate category was associated with female gender and family history of heart attack. Subjects with ≥80 were also more likely to have hypertension and diabetes, be overweight, spend less time exercising each week and less frequent use of AV-nodal blocking agents. At the baseline exam 2925 (48.7%) participants had evidence of CAC while the remaining 3079

Discussion

In a population-based study of persons without clinical cardiovascular disease at baseline, we have demonstrated that elevated resting heart rate is associated with atherosclerosis as evidenced by (1) increased incident CAC on follow-up exams among persons without baseline CAC; and (2) greater progression of CAC among persons with evidence of CAC at baseline.

This association was present across ethnic/racial groups and in both males and females. Although race/ethnicity stratified analysis

Conclusion

In a population of subjects without clinical cardiovascular disease at baseline, elevated resting heart rate was associated with the incidence and progression of CAC independently of demographic, anthropomorphic, and risk factor variables as well as physical activity level and use of heart rate slowing medications. This study supports the hypothesis that increased heart rate is associated with accelerated atherosclerosis. This may imply that the increased risk associated with an elevated

Sources of funding

This research was supported by contracts N01-HC-95159 through N01-HC-95169 from the National Heart, Lung, and Blood Institute. J.R. was supported by National Heart, Lung, and Blood Institute grant 5T32HL007024.

Disclosures

Dr. Budoff is on the Speaker's Bureau for GE Healthcare.

Acknowledgements

The authors thank the other investigators, the staff, and the participants of the MESA study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org.

References (31)

C. Perret-Guillaume et al.
Heart rate as a risk factor for cardiovascular disease
Prog Cardiovasc Dis
(2009)
J.A. Panza et al.
Role of increases in heart rate in determining the occurrence and frequency of myocardial ischemia during daily life in patients with stable coronary artery disease
J Am Coll Cardiol
(1992)
K. Fox et al.
Resting heart rate in cardiovascular disease
J Am Coll Cardiol
(2007)
R. Erbel et al.
Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study
J Am Coll Cardiol
(2010)
A.S. Agatston et al.
Quantification of coronary artery calcium using ultrafast computed tomography
J Am Coll Cardiol
(1990)
P. Palatini
Elevated heart rate: a “new” cardiovascular risk factor?
Prog Cardiovasc Dis
(2009)
I. Janssen et al.
The Cooper Clinic Mortality Risk Index: clinical score sheet for men
Am J Prev Med
(2005)
A. Perski et al.
Minimum heart rate and coronary atherosclerosis: independent relations to global severity and rate of progression of angiographic lesions in men with myocardial infarction at a young age
Am Heart J
(1992)
M. Blaha et al.
Absence of coronary artery calcification and all-cause mortality
JCMG
(2009)
S. Shareghi et al.
Prognostic significance of zero coronary calcium scores on cardiac computed tomography
J Cardiovasc Comput Tomogr
(2007)

J.W. McEvoy et al.

Coronary artery calcium progression: an important clinical measurement? A review of published reports

J Am Coll Cardiol

(2010)

M.J. Budoff et al.

Progression of coronary artery calcium predicts all-cause mortality, JACC

Cardiovasc Imaging

(2010)

D. Kovar et al.

Does initial and delayed heart rate predict mortality in patients with acute coronary syndromes?

Clin Cardiol

(2004)

P. Palatini et al.

Elevated heart rate: a major risk factor for cardiovascular disease

Clin Exp Hypertens

(2004)

X. Jouven et al.

Heart-rate profile during exercise as a predictor of sudden death

N Engl J Med

(2005)

Cited by (28)

Psychophysiological Bases of Disease
2022, Comprehensive Clinical Psychology, Second Edition
Psychological and social factors are thought to influence risk for a range of physical illnesses including coronary heart disease, high blood pressure, type 2 diabetes, infectious illness, bronchial asthma and musculoskeletal pain. These associations are underpinned by the impact of psychological stress and other biobehavioral stimuli on the systemic biological responses implicated in disease risk. Several systems are involved, with cardiovascular, neuroendocrine, immune, inflammatory, metabolic and musculoskeletal responses all being relevant. The nature and extent of influence on health outcomes varies across diseases, and different types of study design are needed to evaluate these processes in different health conditions.
Effects of selective heart rate reduction with ivabradine on LV function and central hemodynamics in patients with chronic coronary syndrome
2021, IJC Heart and Vasculature
We assessed left ventricular (LV) function and central hemodynamic effects in patients with a heart rate (HR) at rest of ≥70 beats per minute (bpm) and chronic coronary syndrome (CCS) after long-term treatment with ivabradine compared to placebo by cardiac magnetic resonance (CMR) imaging.
In a randomized, double-blinded, prospective cross-over design, 23 patients (18 male, 5 female) were treated with ivabradine (7.5 mg bid) or placebo for 6 months. CMR imaging was performed at baseline and after 6 and 12 months to determine LV functional parameters.
Mean resting HR on treatment with ivabradine was 58 ± 8.2 bpm and 70.2 ± 8.3 bpm during placebo (p < 0.0001).There was no difference in systolic LV ejection fraction (ivabradine 57.4 ± 11.2% vs placebo 53.0 ± 10.9%, p = 0.18), indexed end-diastolic (EDVi) or end-systolic volumes (ESVi). Indexed stroke volume (SVi) (ml/m²) remained unchanged after treatment with ivabradine. Volume time curve parameters reflecting systolic LV function (peak ejection rate and time) were unaffected by ivabradine, while both peak filling rate (PFR) and PFR/EDV were significantly increased. Mean aortic velocity (cm/s) was significantly reduced during treatment with ivabradine (ivabradine 6.7 ± 2.7 vs placebo 9.0 ± 3.4, p = 0.01). Aortic flow parameters were correlated to parameters of vascular stiffness. The strongest correlation was revealed for mean aortic velocity with aortic distensibility (AD) (r = −0.86 [−0.90 to −0.85], p < 0.0001).
Long-term reduction of HR with ivabradine in patients with CCS improved diastolic function and reduced mean aortic flow velocity.
Diabetes and calcification: The potential role of anti-diabetic drugs on vascular calcification regression
2020, Pharmacological Research
Vascular calcification (VC) has been well-established as an independent and strong predictor of cardiovascular diseases (CVD) as well as major cardiac adverse events (MACE). VC is associated with increased mortality in patients with CVD. Pathologically, VC is now believed to be a multi-directional active process ultimately resulting in ectopic calcium deposition in vascular beds. On the other hand, prevalence of diabetes mellitus (DM) is gradually increasing thus making the current population more prone to future CVD. Although the mechanisms involved in development and progression of VC in DM patients are not fully understood, a series of evidences demonstrated positive association between DM and VC. It has been highlighted that different cellular pathways are involved in this process. These intermediates such as tumor necrosis factor alpha (TNF-α), various interleukins (ILs) and different cell-signaling pathways are over-expressed in DM patients leading to development of VC. Thus, considering the burden and significance of VC it is of great importance to find a therapeutic approach to prevent or minimize the development of VC in DM patients. Over the past few years various anti diabetic drugs (ADDs) have been introduced and many of them showed desired glucose control. But no study demonstrated the effects of these medications on regression of VC. In this review, we will briefly discuss the current understanding on DM and VC and how commonly used ADDs modulate the development or progression of VC.
Ideal cardiovascular health and resting heart rate in the Multi-Ethnic Study of Atherosclerosis
2020, Preventive Medicine
Citation Excerpt :
The RHR for each study participant was obtained using a 12‑lead electrocardiogram performed at rest during the baseline visit. Based on prior research (Amoakwa et al., 2018; Rubin et al., 2012), RHR was categorized as <60, 60–69, 70–79 and ≥80 bpm and was also assessed as a continuous variable. An individual meets the AHA's definition of ideal CVH if he or she meets the ideal criteria for 4 health behaviors (non-smoking, physical activity at target levels, BMI <25 kg/m2 and recommended healthy diet) and 3 health factors (total cholesterol <200 mg/dL, blood pressure <120/<80 mmHg and fasting blood glucose <100 mg/dL, without the use of medication) (Lloyd-Jones et al., 2010).
Elevated resting heart rate (RHR) is associated with an increased cardiovascular disease (CVD) risk, but little is known about its association with cardiovascular health (CVH), assessed by the Life's Simple 7 (LS7) metrics. We explored whether ideal CVH was associated with RHR in a cohort free from clinical CVD. We conducted a cross-sectional analysis of baseline data (2000−2002) of 6457 Multi-Ethnic Study of Atherosclerosis participants in 2018. Each LS7 metric (smoking, physical activity, diet, body mass index, blood pressure, cholesterol and glucose) was scored 0–2. Total score ranged from 0 to 14. Scores of 0–8 indicate inadequate, 9–10 average, and 11–14 optimal CVH. RHR was categorized as <60, 60–69, 70–79 and ≥80 bpm. We used multinomial logistic regression to determine associations between CVH score and RHR, adjusting for age, sex, race/ethnicity, education, income, health insurance, and atrioventricular nodal blockers. Mean age of participants (standard deviation) was 62 (10) years; 53% were women; 47% had inadequate CVH, 33% average, and 20% optimal. Favorable CVH was associated with lower odds of having higher RHR. Compared to RHR <60 bpm, participants with optimal CVH had adjusted odds ratio (95% CI) of 0.55 (0.46–0.64) for RHR of 60-69 bpm, 0.34 (0.28–0.43) for 70–79 bpm, and 0.14 (0.09–0.22) for ≥80 bpm. A similar pattern was observed in the stratified analysis by sex, race/ethnicity and age. Favorable CVH was less likely to be associated with elevated RHR irrespective of sex, race/ethnicity and age. More research is needed to explore the usefulness of promoting ideal CVH to reduce elevated RHR, a known risk factor for CVD.
Resting heart rate and the incidence and progression of valvular calcium: The Multi-Ethnic Study of Atherosclerosis (MESA)
2018, Atherosclerosis
Citation Excerpt :
Participants underwent a follow-up CT at either examination 2 or examination 3 based on random assignment. While some participants underwent additional CT scans at subsequent MESA examinations (Exams 4 and/or 5) for CAC assessment [12], these latter scans have not yet been measured for valvular calcification and are not available for this analysis. Three sites used electron-beam tomography and three sites used multi-detector CT.
Left-sided valvular calcification is associated with cardiovascular disease (CVD) morbidity and mortality. Resting heart rate (RHR) may influence valvular calcium progression through shear stress. Whether RHR, an established CVD risk factor, is associated with valvular calcium progression is unknown. We assessed whether RHR predicts incidence and progression of mitral annular calcium (MAC) and aortic valve calcium (AVC) in a community-based cohort free of CVD at baseline.
RHR was obtained from baseline electrocardiograms of 5498 MESA participants. MAC and AVC were quantified using Agatston scoring from cardiac computed tomography scans obtained at baseline and at a second examination during follow-up. We examined associations of RHR with incident MAC/AVC and annual change in MAC/AVC scores, after adjusting for demographics, CVD risk factors, physical activity, and atrioventricular nodal blocker use.
At baseline, participants had mean age of 62 ± 10 years and mean RHR of 63 ± 10 bpm; 12.3% and 8.9% had prevalent AVC and MAC, respectively. Over a median of 2.3 years, 4.1% and 4.5% developed incident AVC and MAC, respectively. Each 10 bpm higher RHR was significantly associated with incident MAC [Risk Ratio 1.17 (95% CI 1.03–1.34)], but not incident AVC. However, RHR was associated with AVC progression [β = 1.62 (0.45–2.80) Agatston units/year for every 10 bpm increment], but not MAC progression.
Higher RHR was associated with MAC incidence and AVC progression, independent of traditional CVD risk factors. Future studies are needed to determine whether modification of RHR through lifestyle or pharmacologic interventions can reduce valvular calcium incidence or progression.
Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality – A systematic review and dose–response meta-analysis of prospective studies
2017, Nutrition, Metabolism and Cardiovascular Diseases
Citation Excerpt :
Resting heart rate is considered a sensitive indicator of autonomic nervous system activity and an increase likely reflects sympathetic overactivity. This imbalance is known to stimulate the renin–angiotensin–aldosterone system, leading to increased release of angiotensin 2, which has an adverse effect on the cardiovascular system by promoting the development and progression of atherosclerosis [113]. Chronic activation of the sympathetic system can produce a state of insulin resistance [114,115] which is associated with hypertriglyceridemia, low HDL-cholesterol, and hyperuricemia [116].
Epidemiological studies have reported increased risk of cardiovascular disease, cancer and all-cause mortality with greater resting heart rate, however, the evidence is not consistent. Differences by gender, adjustment for confounding factors, as well as the potential impact of subclinical disease are not clear. A previous meta-analysis missed a large number of studies, and data for atrial fibrillation have not been summarized before. We therefore aimed to clarify these associations in a systematic review and meta-analysis of prospective studies.
PubMed and Embase were searched up to 29 March 2017. Summary RRs and 95% confidence intervals (CIs) were calculated using random effects models. Eighty seven studies were included. The summary RR per 10 beats per minute increase in resting heart rate was 1.07 (95% CI: 1.05–1.10, I² = 61.9%, n = 31) for coronary heart disease, 1.09 (95% CI: 1.00–1.18, I² = 62.3%, n = 5) for sudden cardiac death, 1.18 (95% CI: 1.10–1.27, I² = 74.5%, n = 8) for heart failure, 0.97 (95% CI: 0.92–1.02, I² = 91.4%, n = 9) for atrial fibrillation, 1.06 (95% CI: 1.02–1.10, I² = 59.5%, n = 16) for total stroke, 1.15 (95% CI: 1.11–1.18, I² = 84.3%, n = 35) for cardiovascular disease, 1.14 (95% CI: 1.06–1.23, I² = 90.2%, n = 12) for total cancer, and 1.17 (95% CI: 1.14–1.19, I² = 94.0%, n = 48) for all-cause mortality. There was a positive dose–response relationship for all outcomes except for atrial fibrillation for which there was a J-shaped association.
This meta-analysis found an increased risk of coronary heart disease, sudden cardiac death, heart failure, atrial fibrillation, stroke, cardiovascular disease, total cancer and all-cause mortality with greater resting heart rate.

View all citing articles on Scopus

View full text

The relationship between resting heart rate and incidence and progression of coronary artery calcification: The multi-ethnic study of atherosclerosis (MESA)

Abstract

Objective

Methods

Results

Conclusion

Introduction

Section snippets

Study population

Results

Discussion

Conclusion

Sources of funding

Disclosures

Acknowledgements

Prog Cardiovasc Dis

J Am Coll Cardiol

J Am Coll Cardiol

J Am Coll Cardiol

J Am Coll Cardiol

Prog Cardiovasc Dis

Am J Prev Med

Am Heart J

JCMG

J Cardiovasc Comput Tomogr

J Am Coll Cardiol

Cardiovasc Imaging

Does initial and delayed heart rate predict mortality in patients with acute coronary syndromes?

Clin Cardiol

Elevated heart rate: a major risk factor for cardiovascular disease

Clin Exp Hypertens

Heart-rate profile during exercise as a predictor of sudden death

N Engl J Med